Association Between Apolipoprotein E Genotype and Alzheimer Disease in African American Subjects
Open Access
- 1 April 2002
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 59 (4) , 594-600
- https://doi.org/10.1001/archneur.59.4.594
Abstract
A GENETIC BASIS for Alzheimer disease (AD) is well established.1 Survival analysis suggests that the risk for AD is 2 to 3 times higher among first-degree relatives of patients with AD compared with nonrelatives.2 This trend is evident in multiple ethnic groups, including white,3-5 Hispanic,6 and African American6,7 subjects. Mutations in the amyloid precursor protein and presenilin 1 and 2 genes may be responsible for as much as 50% of familial (ie, autosomal dominant) AD beginning before 60 years of age1,8-10; however, these defects have a low epidemiological impact, accounting for less than 1% of patients worldwide.11This publication has 16 references indexed in Scilit:
- Risk of Dementia Among White and African American Relatives of Patients With Alzheimer DiseaseJAMA, 2002
- Familial Aggregation of Alzheimer Disease Among Whites, African Americans, and Caribbean Hispanics in Northern ManhattanArchives of Neurology, 2000
- High Prevalence of Pathogenic Mutations in Patients with Early-Onset Dementia Detected by Sequence Analyses of Four Different GenesAmerican Journal of Human Genetics, 2000
- Early-Onset Autosomal Dominant Alzheimer Disease: Prevalence, Genetic Heterogeneity, and Mutation SpectrumAmerican Journal of Human Genetics, 1999
- Apolipoprotein E ϵ4 Allele and Familial Aggregation of Alzheimer DiseaseArchives of Neurology, 1998
- Estimation of the Genetic Contribution of Presenilin-1 and -2 Mutations in a Population-Based Study of Presenile Alzheimer DiseaseHuman Molecular Genetics, 1998
- Effects of apolipoprotein E on dementia and aging in the Shanghai Survey of DementiaNeurology, 1997
- GENETICS AND THE DEMENTIA PATIENTThe Neurologist, 1997
- Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseNature Genetics, 1994
- Apolipoprotein E genotyping by one-stage PCRThe Lancet, 1991